{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:50:09Z","timestamp":1771984209025,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.ahj.2008.12.017","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T02:19:04Z","timestamp":1235269144000},"page":"746-753.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study"],"prefix":"10.1016","volume":"157","author":[{"given":"James A.","family":"de Lemos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren K.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Khera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep R.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torbjorn","family":"Omland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Drazner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.12.017_bib1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1001\/jama.292.19.2350","article-title":"Prognostic significance of left ventricular mass change during treatment of hypertension","volume":"292","author":"Devereux","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.12.017_bib2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.12.017_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"108","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.12.017_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors","volume":"327","author":"The SOLVD Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.12.017_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(01)05620-3","article-title":"Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study","volume":"358","author":"Davies","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.12.017_bib6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7326\/0003-4819-138-11-200306030-00012","article-title":"The epidemiology of \u201casymptomatic\u201d left ventricular systolic dysfunction: implications for screening","volume":"138","author":"Wang","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2008.12.017_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.12.017_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease","volume":"362","author":"de Lemos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.12.017_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.12.017_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.12.017_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(97)03034-1","article-title":"Biochemical detection of left-ventricular systolic dysfunction","volume":"351","author":"McDonagh","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.12.017_bib12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jama.288.10.1252","article-title":"Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study","volume":"288","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.12.017_bib13","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1161\/01.CIR.0000130845.38133.8F","article-title":"Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study","volume":"109","author":"Redfield","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.12.017_bib14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2004.12.058","article-title":"Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides","volume":"45","author":"Ng","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.12.017_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.2003.026021","article-title":"Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population","volume":"90","author":"Groenning","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2008.12.017_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2005.09.025","article-title":"Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction","volume":"47","author":"Costello-Boerrigter","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.12.017_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehi410","article-title":"What is the normal range for N-terminal pro-brain natriuretic peptide? Howe well does this normal range screen for cardiovascular disease?","author":"Galasko","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.12.017_bib18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.amjcard.2004.02.058","article-title":"The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health","volume":"93","author":"Victor","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.12.017_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.HYP.0000169972.96201.8e","article-title":"Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study","volume":"46","author":"Drazner","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2008.12.017_bib20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/eurheartj\/ehi083","article-title":"Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography","volume":"26","author":"Hoffmann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.12.017_bib21","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"de Lemos","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.12.017_bib22","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.12.017_bib23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9149(02)02464-5","article-title":"Impact of age and sex on plasma natriuretic peptide levels in healthy adults","volume":"90","author":"Wang","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.12.017_bib24","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.amjcard.2005.06.073","article-title":"Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study)","volume":"96","author":"Abdullah","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.12.017_bib25","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/00004872-200018080-00018","article-title":"Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population","volume":"18","author":"Luchner","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2008.12.017_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/oxfordjournals.aje.a117485","article-title":"Meta-analysis of Pap test accuracy","volume":"141","author":"Fahey","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2008.12.017_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa021659","article-title":"Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen","volume":"349","author":"Punglia","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.12.017_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0895-7061(94)00178-E","article-title":"Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient","volume":"8","author":"Bottini","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2008.12.017_bib29","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.HYP.0000216794.24161.8c","article-title":"Amino-terminal pro\u2013B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure","volume":"47","author":"McKie","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2008.12.017_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.12.017_bib31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.293.13.1609","article-title":"N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults","volume":"293","author":"Kistorp","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.12.017_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehl448","article-title":"N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population","author":"Olsen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.12.017_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ahj.2004.06.009","article-title":"Unexpected BNP levels in patients with advanced heart failure: a tale of caution and promise","volume":"149","author":"Drazner","year":"2005","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870309000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870309000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:38:51Z","timestamp":1757569131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870309000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0002870309000039"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.12.017","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2008.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}